ArticleFrontiers in drug safety and regulation2025

Rethinking drug safety signal detection and causality assessment in the age of AI: the risks of incomplete data and biased insights.

Priyanka Chhikara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.